QUiCKR Bio
6 employees on LinkedIn · 3 known investors
QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
Founders & leadership
CB
Charles BlanluetinCEO & Founder
Investors · 3
Competitors · 3
by search overlap
IQVIA3 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Qu Biologics3 shared keywordsQu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
Molecular Devices3 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
Companies competing with QUiCKR Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does QUiCKR Bio do?
- QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
- Who founded QUiCKR Bio?
- QUiCKR Bio was founded by Charles Blanluet.
- Who are QUiCKR Bio's investors?
- QUiCKR Bio's investors include Civilization Ventures Management, Llc, HCVC, Lexi Ventures.